Indian Army Pharmaceutical Formulations Supply Procurement

Work Description - NA

This tender, bid number GEM/2026/B/7581225, is issued by the Department of Military Affairs, under the Ministry of Defence, for the Indian Army, with the Kolkata office serving as the administering authority. The bid period commences on September 1, 2026, at 5:00 PM and concludes on September 2, 2026, at 5:00 PM. The total quantity of items required is 1,930,600 units. The procurement encompasses a diverse range of pharmaceutical formulations, including but not limited to 5 Amino Salicylic Acid SR 1.2 g Tablets, Tab Acarbose 25 mg, Tab Acebrophylline 100 mg, Tab NAC plus Acebrophylline, Tab Acebrophylline 200 mg SR, Alfuzosin 10 mg Tablets, Alprazolam 0.5 Mg Tablets, Amitriptyline 10 mg Tablets, Amitriptyline 25 mg Tablets, Amoxycillin 500 mg plus Clavulanic Acid 125 mg Tablets, Anastrozole 1mg Tablets, Antacid chewable containing dried Aluminium Hydroxide IP 250 mg, Atorvastatin 10mg Tablets, Tab Hydralazine 37.5 mg plus Isosorbide Dinitrate 20 mg, Diclofenac 25 mg per ml IP 3ml Injection, Tab Lamivudine 150 mg, Tab Lemborexant 0.5 mg, Lopinavir 200 mg plus Ritonavir 50 mg co-formulation, Indapamide SR 1.5 mg Tablets, Tab Gliclazide 40 mg, and Lamotrigine 25 mg Tablets. This tender represents a significant opportunity to supply essential pharmaceutical products to a critical governmental organization.